An investigation of male-mediated F1 effects in mice treated acutely and sub-chronically with urethane.
In order to investigate the alleged potential of paternally administered urethane to cause foetal abnormalities and heritable tumours, male CD-1 mice were treated with urethane, either acutely by intraperitoneal injection at doses of 1.25 and 1.75 g/kg bodyweight (bwt) or sub-chronically in the drinking water at 1.25 for 10 weeks, and 3.75 mg/ml for 9 weeks or vehicle for the control groups. They were mated to untreated females 1 week later. Uterine contents of half the pregnant females were examined just before full term, while the remaining females were allowed to deliver their litters. The resulting F1 offspring were observed for approximately 18 months and 12 months for acute and sub-chronic exposures respectively and subjected to necropsy examination. Some of the mice treated acutely with 1.75 g/kg bwt exhibited partial infertility but none of those treated with 1.25 g/kg bwt had an adverse effect on their reproductive ability. There was no genetic effect of acute urethane treatment on male germ cells as indicated by dominant lethality. After birth, there was an increase (P < 0.05) in post-implantation deaths possibly due to perinatal mortality. There was an increased incidence and earlier onset of liver tumours induced in F1 male offspring from F0 males treated with 1.75 g/kg bwt, (20.7% vs. 10.1%, P = 0.026) but not in the female offspring. F1 males from both treatment groups had mean bodyweights significantly higher than controls (P < 0.01). Some males from each dose group of the acute study were examined using the restriction site mutation assay involving analysis of exon sequences. No mutations were identified in testes, liver or spleen of DNA isolated from the urethane-treated animals. No reproductive or genetic effects were seen with sub-chronic treatment at either 1.25 or 3.75 mg/ml urethane nor was there any predisposition of F1 animals to tumours although observation times were shorter.
Edwards
A J
AJ
BIBRA International, Carshalton, Surrey, United Kingdom.
Anderson
D
D
Brinkworth
M H
MH
Myers
B
B
Parry
J M
JM
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D001835:Body Weight; D002273:Carcinogens / Q000378:metabolism / Q000633:toxicity*; D004252:DNA Mutational Analysis; D005260:Female; D007246:Infertility; D007621:Karyotyping; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced*; D018812:Paternal Exposure; D012150:Polymorphism, Restriction Fragment Length; D011247:Pregnancy; D014520:Urethane / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*
D002273:Carcinogens; D014520:Urethane